Kim Papp Selected Research

GSK2982772

10/2020

Response to Inhibition of Receptor-Interacting Protein Kinase 1 (RIPK1) in Active Plaque Psoriasis: A Randomized Placebo-Controlled Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kim Papp Research Topics

Disease

77	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2024 - 09/2004
20	Psoriatic Arthritis 03/2024 - 04/2009
19	Atopic Dermatitis (Atopic Eczema) 05/2024 - 07/2002
14	Infections 12/2022 - 07/2002
4	Respiratory Tract Infections (Respiratory Tract Infection) 12/2022 - 11/2016
4	Inflammation (Inflammations) 12/2022 - 08/2012
4	Nasopharyngitis 01/2022 - 04/2011
4	Neoplasms (Cancer) 02/2020 - 12/2005
3	Eczema 05/2024 - 07/2002
3	Myocardial Infarction 09/2023 - 03/2010
3	Chronic Disease (Chronic Diseases) 01/2023 - 01/2006
3	Acne Vulgaris 06/2022 - 02/2008
3	Headache (Headaches) 06/2022 - 07/2010
3	Pruritus (Itching) 09/2020 - 08/2002
2	Fatigue 01/2023 - 01/2006
2	Conjunctivitis 12/2022 - 03/2018
2	Injection Site Reaction 12/2022 - 11/2016
2	Nausea 06/2022 - 01/2022
2	Body Weight (Weight, Body) 01/2022 - 10/2015
2	Ulcerative Colitis 01/2021 - 02/2020
2	Rheumatoid Arthritis 01/2021 - 01/2017
2	Skin Neoplasms (Skin Cancer) 02/2020 - 07/2015
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2020 - 01/2018
2	Ankylosing Spondylitis 03/2019 - 04/2009
2	Candidiasis (Moniliasis) 01/2018 - 10/2015
2	Hypertension (High Blood Pressure) 01/2017 - 07/2012
2	Necrosis 01/2013 - 10/2005
1	Hidradenitis Suppurativa 10/2023
1	Pain (Aches) 01/2023
1	3 Atopic Dermatitis 01/2023
1	Opportunistic Infections (Opportunistic Infection) 12/2022
1	Kaposi Varicelliform Eruption (Eczema Herpeticum) 12/2022
1	Herpes Zoster 06/2022
1	Herpes Simplex 06/2022
1	Diarrhea 01/2022
1	Celiac Disease (Celiac Sprue) 01/2022

Drug/Important Bio-Agent (IBA)

16	Monoclonal AntibodiesIBA 02/2024 - 10/2005
11	CytokinesIBA 12/2022 - 07/2002
9	InterleukinsIBA 09/2023 - 12/2008
8	risankizumabIBA 03/2024 - 01/2022
8	Interleukin-17 (Interleukin 17)IBA 01/2022 - 07/2014
8	Adalimumab (Humira)FDA Link 01/2018 - 01/2008
7	brodalumabIBA 01/2024 - 12/2014
7	ixekizumabIBA 03/2022 - 01/2015
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 10/2005
6	ruxolitinibIBA 05/2024 - 01/2020
5	calcipotriene (calcipotriol)FDA LinkGeneric 02/2024 - 09/2010
5	apremilastIBA 01/2022 - 08/2012
5	Ointments (Pastes)IBA 01/2020 - 09/2010
4	Interleukin-23 (Interleukin 23)IBA 10/2023 - 01/2022
4	Ustekinumab (CNTO 1275)FDA Link 10/2015 - 12/2008
4	Etanercept (Enbrel)FDA Link 08/2015 - 01/2006
4	Infliximab (Remicade)FDA Link 07/2015 - 10/2005
4	Clobetasol (Clobetasol Propionate)FDA LinkGeneric 10/2011 - 01/2010
4	Alefacept (Amevive)FDA Link 12/2009 - 12/2005
4	efalizumab (Raptiva)FDA Link 11/2008 - 12/2005
3	betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric 02/2024 - 01/2011
3	secukinumabIBA 09/2023 - 07/2014
3	Interleukin-13IBA 12/2022 - 01/2016
3	Janus Kinase InhibitorsIBA 06/2022 - 06/2020
3	omega-Chloroacetophenone (Mace)IBA 02/2020 - 07/2015
3	Phosphodiesterase 4 InhibitorsIBA 01/2020 - 07/2015
3	dupilumabIBA 09/2018 - 01/2016
3	Interleukin-12 (IL 12)IBA 01/2018 - 12/2008
3	SteroidsIBA 01/2018 - 07/2011
3	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 07/2015 - 08/2012
3	golimumab FDA Link 01/2013 - 04/2009
3	pimecrolimus (Elidel)FDA Link 12/2004 - 07/2002
2	Immunoglobulin A (IgA)IBA 05/2024 - 09/2017
2	upadacitinibIBA 11/2023 - 01/2021
2	Antirheumatic Agents (DMARD)IBA 11/2023 - 01/2022
2	guselkumabIBA 10/2023 - 09/2023
2	AerosolsIBA 06/2022 - 01/2016
2	baricitinibIBA 01/2022 - 07/2021
2	abrocitinibIBA 10/2020 - 09/2020
2	Calcineurin InhibitorsIBA 11/2011 - 03/2006
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2011 - 10/2011
2	Vitamin D FDA LinkGeneric 11/2011 - 10/2011
2	Calcitriol (Calcijex)FDA LinkGeneric 10/2011 - 07/2011
2	siplizumabIBA 07/2010 - 07/2009
1	Peptides (Polypeptides)IBA 02/2024
1	mirikizumabIBA 09/2023
1	Interleukin-23 Subunit p19IBA 09/2023
1	tralokinumabIBA 12/2022
1	Janus KinasesIBA 06/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 06/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	Glutens (Glutelin)IBA 01/2022
1	AntipruriticsIBA 10/2021
1	Janus Kinase 2IBA 07/2021
1	Janus Kinase 1IBA 07/2021
1	tofacitinibIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 10/2020
1	GSK2982772IBA 10/2020

Therapy/Procedure

33	Therapeutics 01/2023 - 09/2004
9	Biological Therapy 01/2024 - 02/2007
4	Phototherapy (Light Therapy) 07/2012 - 09/2004
2	Aftercare (After-Treatment) 07/2020 - 01/2016
1	Oral Administration 02/2024